Foot & Ankle Clinic Application for Liposomal Related Anesthetic

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of this study is to review the use of surgeon applied liposomal release anesthetic (Exparel) for post operative analgesia. Hypothesis: Surgeon applied use of liposomal related anesthetic provides excellent post operative analgesia. Immediated and 72 hour narcotic use will be significantly impacted by the use of this modality.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00942032` - Clinical Experience With the Hindfoot Arthrodesis Nail for the Surgical Treatment of Ankle and Hindfoot Pathologies	N/A

NCT number	NCT02586077
Study type	Interventional
Source	OrthoCarolina Research Institute, Inc.
Contact
Status	Completed
Phase	Phase 4
Start date	February 1, 2014
Completion date	November 15, 2016

Foot and Ankle Clinic Application for Liposomal Related Anesthetic

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms